Two posters selected for IDF Congress 2023. Primary prevention of diabetes mellitus type 2 AK Niazi, K Shafique, PEH Schwartz BIDE's Diabetes Desk Book, 427-445
Adil, S.O., Musa, K.I., Uddin, F. et al. Prevalence of undiagnosed metabolic syndrome using three different definitions and identifying associated risk factors among apparently healthy adults in Karachi, Pakistan: a cross-sectional survey in the year 2022. Arch Public Health 82, 22 (2024).
Khan, A., Kanpurwala, M.A., Khan, R.A. et al. Impact of Treviamet® & Treviamet XR® on quality of life besides glycemic control in type 2 DM patients. BMC Endocr Disord 23, 244 (2023).
Adil, S. O., Uddin, F., Musa, K. I., Khan, A. K. A., Shakeel, A., Shafique, K., & Islam, A. (2023). Risk assessment for cardiovascular disease using the Framingham risk Score and Globorisk score among newly diagnosed metabolic syndrome patients. International Journal of General Medicine, Volume 16, 4295–4305.
Adil, S. O., Musa, K. I., Uddin, F., Shafique, K., Khan, A. K. A., & Islam, A. (2023). Role of anthropometric indices as a screening tool for predicting metabolic syndrome among apparently healthy individuals of Karachi, Pakistan. Frontiers in Endocrinology, 14.
Khan, Asima, Izhan A. Khan, Hussain Abidi, and Mansoor Ahmed. “Comparison of Empagliflozin and Vildagliptin for Efficacy and Safety in Type 2 Diabetes Mellitus in the Pakistani Population.” Frontiers in Endocrinology 13 (2022).
Khan., Izhan Ali, Asima Khan, Fauzia Imtiaz, and Mukarum Ali. “Major Causes of Negative and Positive Impacts on Mental Health during Lock down Due to Covid
